
Gan & Lee Pharmaceuticals.
SSE:603087.SS
Overview | Financials
Company Name | Gan & Lee Pharmaceuticals. |
Symbol | 603087.SS |
Currency | CNY |
Price | 58.72 |
Market Cap | 34,717,463,651 |
Dividend Yield | 0% |
52-week-range | 37.63 - 59.16 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Gan Zhongru |
Website | https://www.ganlee.com |
An error occurred while fetching data.
About Gan & Lee Pharmaceuticals.
Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and commercialization insulin analogues primarily in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro; Raplin, an insulin aspart injection; Raplin 30, an insulin aspart 30 injection;
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD